...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Academic radiology >The ductal carcinoma in situ (DCIS) dilemma.
【24h】

The ductal carcinoma in situ (DCIS) dilemma.

机译：导管原位癌（DCIS）困境。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Detecting, classifying (grading), treating, and managing ductal carcinoma in situ (DCIS), and other high-risk abnormalities (eg, atypical ductal hyperplasia [ADH]), of the breast remains an ever-evolving, compalicated, extremely expensive, and controversial area of interest.I recently attended a National Institutes of Health workshop on the topic of "Diagnosis and Management of Ductal Carcinoma In Situ (DCIS)" (1) with the hope of gaining a new perspective mixed with a critical assessment through open discussion about the "big picture issues" we face, only to be surprised as to how little is known about the natural history of this disease (or better yet diseases) and as to the best course of treatment and management of DCIS. As far as I was concerned, this lack of knowledge regarding optimal management of DCIS (which I personally saw as the "huge white elephant in the room") was briefly- mentioned (and largely glanced over or completely ignored) by several speakers rather than being the clear and primary focus of the meeting.
机译：乳房的原位导管癌（DCIS）以及其他高危异常（例如非典型导管增生[ADH]）的检测，分类（分级），治疗和管理仍然是一个不断发展，复杂，极其昂贵的过程，最近，我参加了美国国立卫生研究院关于“导管原位癌的诊断和管理”（DCIS）的研讨会（1），希望借此获得新的观点，并通过公开评估进行严格评估关于我们所面临的“大问题”的讨论，令我们惊讶的是，对这种疾病（或更好的疾病）的自然病史知之甚少，以及对DCIS的最佳治疗和治疗方法知之甚少。就我而言，几位发言者简要提到了DCIS的最佳管理知识（我个人认为这是“房间里的巨大白象”），而对此缺乏了解，而并非是会议的主要重点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号